TIGIT overexpression in CD8+ and CD4+ T cells is correlated with HNSCC progression and a poor treatment response, and TIGIT/PD-1/LAG-3 axis activation is correlated with tumor progression and the development of an immunosuppressive microenvironment [119]. The gene discussed is LAG3; the disease is head and neck squamous cell carcinoma.